Loading...

Oncolytics Biotech ($ONCY)

Stock Image

ONCY Overview

Oncolytics Biotech, a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer.Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC.Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada. (From: StockAnalysis.com)

MORE ABOUT Oncolytics Biotech

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.